Skip to main content
. 2021 May 25;13(11):2587. doi: 10.3390/cancers13112587

Figure 2.

Figure 2

Nomogram and calibration plots: (A) Nomogram based on 109 patients with advanced GISTs treated with sunitinib. (B) Calibration curves with nomogram predicted 1-year, 2-year, and 3-year PFS and actually observed survival.